Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when QUCY files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: QUCY Quantum Cyber N.V. 8-K

Quantum Cyber regains Nasdaq compliance after stock price recovers above $1.00

Filed May 28, 2026 · Period ending May 28, 2026 · ~1 min read

2 key changes 1 section

Key Changes

  • medium

    Nasdaq confirmed the company's stock bid price stayed at or above $1.00 for 10 consecutive trading days (May 13-27, 2026), ending a compliance deficiency that began in March 2026.

  • low

    The company had been notified on March 20, 2026 that its stock failed to maintain the $1.00 minimum bid price for 30 consecutive days, triggering the deficiency period.

Summary

Quantum Cyber has resolved its Nasdaq listing compliance issue after its stock price recovered and maintained a bid price at or above $1.00 per share for the required 10 consecutive trading days. The company received official confirmation from Nasdaq on May 28, 2026, closing out a deficiency period that began in March when the stock had traded below the exchange's minimum $1.00 threshold. For retail investors, this removes the immediate threat of delisting from Nasdaq, which would have significantly reduced liquidity and institutional ownership.

The stock price recovery suggests improved market sentiment over the past two months. However, investors should monitor whether the stock can sustain prices above $1.00, as falling back below this level could trigger another compliance review. The underlying business fundamentals that led to the initial price decline warrant continued attention.

Section-by-Section Diff

Event · Item 8.01 — Other Events

~200 words

Item 8.01 — Other Events filed; see Key Changes for terms.

2 Added
Added Nasdaq compliance regained medium

Added in current filing · verify on EDGAR →

On May 28, 2026, Quantum Cyber N.V. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) stating that for the last 10 consecutive business days, from May 13, 2026, to May 27, 2026, the closing bid price of the Company’s ordinary shares had been at or greater than $1.00 per share. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a) (2).

The company received official notification from Nasdaq that its stock price has remained at or above $1.00 per share for 10 consecutive trading days, ending the deficiency period that began in March 2026. This means the company has cured its prior non-compliance with Nasdaq's minimum bid price requirement and the matter is now closed.

Show 1 minor / wording change
Added Prior deficiency context low

Added in current filing · verify on EDGAR →

As previously reported, on March 20, 2026, the Company received a letter from Nasdaq notifying the Company that its ordinary shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days.

The company provides context that it had been notified of a bid price deficiency in March 2026 when its stock traded below $1.00 for 30 consecutive days. This deficiency has now been resolved approximately $1.00 two months later.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · May 28, 2026 · How we verify